Detection of High- and Low-Risk HPV DNA in Archived Breast Carcinoma Tissues from Ethiopian Women

Figure 1

p16 immunostaining of HPV+ breast tumors with a representative HPV-negative/p16-negative breast tumor tissue. (a) H&E staining of the representative HPV-negative case. (b) Negative p16 immunostaining of the representative HPV-negative case. (c) H&E staining of the HPV39 and HPV6 dual-positive case. (d) Negative p16 immunostaining of the HPV39 and HPV6 dual-positive case. (e) H&E staining of the HPV16-positive case. (f) Strong, diffuse, nuclear, and cytoplasmic p16 immunostaining of the HPV16-positive case.

(a)

(b)

(c)

(d)

(e)

(f)